Assertio therapeutics, inc. (ASRT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Total revenues

192,492

229,504

212,878

235,224

241,295

311,770

363,578

381,498

418,681

380,724

410,228

425,339

441,564

455,897

443,158

437,490

415,312

342,735

426,165

372,794

346,022

390,363

236,369

222,344

184,575

134,205

120,186

116,008

100,155

90,816

76,359

59,599

66,707

132,973

140,968

148,865

0

0

0

License and other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31,515

21,592

26,592

21,592

12,796

10,248

15,885

16,457

18,798

22,071

15,812

19,478

81,798

87,984

95,517

0

0

0

Non-cash PDL royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

242,808

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Cost of sales (excluding amortization of intangible assets)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales (excluding amortization of intangible assets)

-

-

7,646

8,378

-

18,476

35,475

49,896

66,868

72,598

77,552

80,399

81,639

87,414

85,764

86,435

88,335

67,898

50,137

32,746

14,556

15,146

14,068

12,296

9,309

7,091

7,239

7,251

7,005

6,039

4,342

3,729

4,427

5,544

7,424

9,255

0

0

0

Research and development expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development expenses

-

-

6,739

7,390

-

-

7,094

6,728

10,162

-

21,613

30,264

31,766

32,631

29,817

24,034

21,632

17,541

13,234

10,249

6,932

7,116

7,107

6,802

6,817

8,073

9,234

13,165

15,278

15,462

15,059

12,997

13,515

15,187

17,007

18,369

0

0

0

Promotion fee expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,339

34,131

36,207

0

0

0

Other selling, general and administrative expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54,205

36,981

26,071

0

0

0

Selling, general and administrative expenses

111,135

108,866

111,385

108,677

115,230

119,218

142,067

157,508

176,210

195,696

195,841

198,565

200,458

204,498

214,373

211,864

217,369

199,352

169,973

147,986

123,151

121,126

119,639

118,935

111,730

105,176

101,725

102,183

101,836

97,646

95,162

89,804

85,814

81,544

71,112

62,278

0

0

0

Amortization of intangible assets

84,174

101,774

101,730

101,729

101,730

101,774

101,872

102,163

102,454

102,745

102,938

104,241

105,543

106,845

108,171

108,147

107,841

83,344

58,824

34,351

10,162

10,161

9,086

7,704

6,125

4,548

4,041

2,988

0

-

0

0

-

-

-

-

-

-

-

Restructuring Charges

-

-

1,859

5,770

-

20,601

19,176

18,706

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on settlement agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,000

0

0

0

0

0

Total costs and expenses

406,624

423,932

229,403

231,988

245,902

268,111

339,522

365,832

402,858

422,904

401,819

416,910

419,406

431,388

463,125

455,480

460,177

393,135

292,168

225,332

154,801

153,549

149,900

145,737

133,981

124,888

122,240

126,441

127,103

121,169

115,626

106,635

103,756

62,275

55,543

49,902

0

0

0

(Loss) income from operations

-214,132

-194,428

-16,525

3,236

-4,607

43,659

24,056

15,666

15,823

-42,180

8,409

8,429

22,158

24,509

-19,967

-17,990

-44,865

-50,400

133,997

147,462

191,221

236,814

86,469

76,607

50,594

9,317

-2,054

-10,433

-26,948

-30,353

-39,267

-47,036

-37,049

70,698

85,425

98,963

0

0

0

Other income (expense):
Interest and other income

-

-

-

-

-

-

-

-

-

-

779

820

605

485

729

678

672

599

325

286

245

215

589

593

619

662

220

289

447

520

154

468

621

557

946

592

0

0

0

Gain (Loss) on Extinguishment of Debt

0

-

0

-

0

-

0

-

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

50,509

58,389

61,881

65,199

67,367

68,881

70,123

70,748

71,496

73,552

76,234

78,726

81,116

83,719

85,884

88,211

90,141

73,436

56,857

36,133

14,671

9,275

3,622

1,997

1,421

911

480

0

0

-

0

-

-

133

262

395

0

0

0

Loss on prepayment of Senior Notes

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

1,232

3,948

-2,389

-948

359

1,197

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense on PDL liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,646

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense)

0

-

0

-

0

-

0

-

-

-61,745

0

0

0

-

-90,932

-93,310

-89,469

-72,837

-56,532

-40,211

-23,693

-23,706

-22,167

-16,174

-10,669

-4,737

-221

94

292

481

114

443

557

424

684

197

0

0

0

Net income (loss) before income taxes

-165,115

-222,484

-54,410

-911

-9,615

37,975

33,473

-38,147

-43,887

-103,925

-72,410

-74,841

-64,130

-64,502

-110,899

-111,300

-134,334

-123,237

77,465

107,251

167,528

213,108

64,302

60,433

39,925

4,580

-2,275

-10,339

-26,656

-29,872

-39,153

-46,593

-36,492

71,122

86,109

99,160

0

0

0

Income tax expense

-3,483

-5,283

-5,674

2,886

1,625

1,100

5,531

-1,827

-1,956

-1,429

41,332

35,803

30,396

24,200

-35,880

-37,390

-49,312

-47,499

27,913

39,460

65,338

81,346

-14,638

-18,567

-26,807

-38,733

-85

-140

-199

-91

762

403

403

396

-344

5

0

0

0

Net Income (Loss) Attributable to Parent

-161,670

-217,201

-48,713

-3,774

-11,217

36,908

27,942

-36,320

-41,931

-102,496

-113,760

-110,662

-94,544

-88,720

-75,019

-73,910

-85,022

-75,738

49,552

67,791

102,190

131,762

78,940

79,000

66,732

43,313

-2,190

-10,199

-26,457

-29,781

-39,915

-46,996

-36,895

70,726

86,453

99,155

0

0

0

Other comprehensive income:
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

-

-

-

Comprehensive income (loss)

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

Basic net income (loss) per share (in dollars per share)

0.58

-2.69

0.05

-0.21

-0.22

-0.38

0.76

-0.33

0.53

-0.52

-0.25

-0.43

-0.43

-

-

-

-

-

-

-

-0.20

1.62

0.11

0.22

0.31

0.74

0.11

0.01

-0.10

-0.06

-0.03

-0.28

-0.16

-0.29

-0.15

-0.11

1.85

0.04

0.08

Diluted net income (loss) per share (in dollars per share)

0.58

-2.69

0.05

-0.21

-0.22

-0.23

0.65

-0.33

0.48

-0.52

-0.25

-0.43

-0.43

-

-

-

-

-

-

-

-0.20

1.43

0.11

0.21

0.30

0.73

0.11

0.01

-0.10

-0.06

-0.03

-0.28

-0.16

-0.25

-0.15

-0.11

1.77

0.04

0.08

Shares used in computing basic net income (loss) per share (in shares)

70,940

81,398

72,747

64,480

64,239

64,037

63,917

63,719

63,503

63,150

62,997

62,531

62,128

-

-

-

-

-

-

-

59,560

58,951

58,567

58,105

57,545

57,101

56,818

56,562

56,460

56,189

56,039

55,786

55,554

55,469

55,371

54,056

53,353

52,595

52,436

Shares used in computing diluted net income (loss) per share (in shares)

71,051

81,398

72,747

64,480

64,239

28,546

82,690

63,719

81,877

63,150

62,997

62,531

62,128

-

-

-

-

-

-

-

59,560

84,011

60,864

60,430

59,923

58,911

57,661

57,142

56,460

56,189

56,039

55,786

55,554

59,177

55,371

54,056

55,754

53,306

53,103

Basic and diluted net loss per share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.21

-0.17

-0.34

-

-0.20

-0.36

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares used in computing basic and diluted net loss per share (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

61,422

61,166

60,898

-

60,320

59,991

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales, net
Total revenues

91,608

108,806

109,228

111,161

112,062

129,966

194,786

260,555

333,949

379,880

409,396

424,495

440,780

455,066

442,450

436,873

414,651

341,750

264,575

190,433

124,383

114,219

99,124

84,818

70,679

58,302

52,002

45,408

34,503

27,483

15,503

15,024

27,976

41,178

50,498

52,950

0

0

0

Commercialization agreement, net
Total revenues

99,016

118,614

102,146

102,623

102,799

155,743

142,760

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalties and milestones
Total revenues

1,868

2,084

1,504

21,440

26,434

26,061

26,032

5,964

932

844

832

844

784

831

708

617

661

985

1,399

1,639

1,860

1,821

1,697

16,749

31,416

45,003

57,936

54,715

49,195

44,535

38,785

28,763

19,253

9,997

2,486

398

0

0

0

Gralise
Total revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) on sale of assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NUCYNTA
Gain (loss) on sale of assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-